Metformin and erlotinib synergize to inhibit basal breast cancer.
Lau YK, Du X, Rayannavar V, Hopkins B, Shaw J, Bessler E, Thomas T, Pires MM, Keniry M, Parsons RE, Cremers S, Szabolcs M, Maurer MA.
Lau YK, et al. Among authors: cremers s.
Oncotarget. 2014 Nov 15;5(21):10503-17. doi: 10.18632/oncotarget.2391.
Oncotarget. 2014.
PMID: 25361177
Free PMC article.